Fresh analysis reveals that patients who stop using new weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who halt conventional diet and exercise plans.
Research printed in a major health publication demonstrates that while overweight individuals can lose about a fifth of their body weight while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month after stopping.
"Users purchasing such treatments should be informed of the danger of fast weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain means a reversion to pre-treatment mass in about a year and a half.
Analyzing Approaches
The study, which reviewed dozens of trials involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.
Scientists emphasize that people who lose weight through dieting typically experience a more gradual weight regain—around 0.1 kg a month—post-intervention.
The Reason for the Quick Rebound
Doctors suggest the mode of action of the injections is key to understanding the accelerated rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating a significant risk."
A Chronic Disease?
Health authorities recommend the jabs for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts contend that, given the high risk of weight regain, the treatment is often long-term.
This opinion is echoed by pharmaceutical companies, who note that the findings "underscore the long-term character of excess weight," akin to managing diseases like diabetes.
User Testimonies
People who have stopped the jabs describe a powerful return of cravings.
"It was like a trigger activating and you become starving," described one woman.
This difficulty is exacerbated if users have not adopted lasting lifestyle or habit modifications during therapy.
Widespread Adoption
Survey data show that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Use is more common among women than males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, experts emphasize that while the jabs are effective tools for shedding pounds, they are not a permanent solution and lasting health benefits relies on ongoing behavioural support.
